Clinical Trial Update: An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors. [EARLY_Phase 1]

View source ↗

Summary

An early-phase, open-label, single-arm trial evaluating KT032 cell injections for safety, tolerability, pharmacokinetics, and preliminary efficacy in mesothelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Malignant Mesothelioma
• Ovarian Cancer

Drugs mentioned

• KT032 cell injection

Snippet

Sponsor: Weijia Fang, MD | Conditions: Ovarian Cancer, Mesothelioma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING